Buformin is an orally active biguanide antidiabetic agent that acts as a potent AMPK activator, reducing hepatic gluconeogenesis and lowering blood glucose levels; it also exhibits anticancer activity and can be used in cancer research, particularly in studies involving cervical and breast cancers.